Ceftazidime is a third-generation parenteral cephalosporin with potent antipseudomonal activity, used for severe Gram-negative infections and frequently combined with avibactam to extend activity against resistant organisms. Simson Pharma's Ceftazidime reference standard and impurities support the demanding QC this critical-care antibiotic requires.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Ceftazidime Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.